Vault-13

ARMISTICE CAPITAL, LLC

NEW YORK, NY · CIK 1601086 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2015 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 15
Southampton, NYUnited States United States3
Miami, FLUnited States United States1

US visa salary filings

Job titleFilingsMedianRange
Financial EngineerNew York, NY 2 $220,000 $220,000 – $225,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Armistice Capital LLC.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$3.9bn reported value +11.6% vs Q1 2022
176positions
30.8%in top 10
77 new 44 added 23 reduced 40 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INCYTE CORP COM INCY INCY 2,000,000 $151.9m3.88% 3.88% AddedShares held: Q3 2021 2.4m, Q4 2021 2.2m, Q1 2022 1.5m, Q2 2022 2.0m +476.0k +476,000 31.2%
2 MIRATI THERAPEUTICS INC COM MRTX MRTX 2,048,000 $137.5m3.51% 3.51% AddedShares held: Q3 2021 710.0k, Q4 2021 836.0k, Q1 2022 1.4m, Q2 2022 2.0m +684.0k +684,000 50.1%
3 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 4,712,000 $136.3m3.48% 3.48% AddedShares held: Q3 2021 3.9m, Q4 2021 4.1m, Q1 2022 3.1m, Q2 2022 4.7m +1.6m +1,612,000 52.0%
4 PTC THERAPEUTICS INC COM PTCT PTCT 3,296,000 $132.0m3.37% 3.37% AddedShares held: Q3 2021 2.6m, Q4 2021 917.1k, Q1 2022 3.0m, Q2 2022 3.3m +260.0k +260,000 8.6%
5 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,324,000 $129.1m3.29% 3.29% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 650.0k, Q2 2022 1.3m +674.0k +674,000 103.7%
6 TRAVERE THERAPEUTICS INC COM TVTX TVTX 5,320,000 $128.9m3.29% 3.29% AddedShares held: Q3 2021 4.7m, Q4 2021 4.1m, Q1 2022 5.0m, Q2 2022 5.3m +362.0k +362,000 7.3%
7 REGENERON PHARMACEUTICALS COM REGN REGN 188,000 $111.1m2.84% 2.84% AddedShares held: Q3 2021 100.0k, Q4 2021 116.0k, Q1 2022 84.0k, Q2 2022 188.0k +104.0k +104,000 123.8%
8 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 2,070,000 $97.8m2.50% 2.50% AddedShares held: Q3 2021 1.8m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 2.1m +946.0k +946,000 84.2%
9 OREILLY AUTOMOTIVE INC COM ORLY ORLY 145,581 $92.0m2.35% 2.35% NewShares held: Q3 2021 66.9k, Q4 2021 60.8k, Q1 2022 0, Q2 2022 145.6k
10 BRISTOL-MYERS SQUIBB CO COM BMY BMY 1,156,000 $89.0m2.27% 2.27% ReducedShares held: Q3 2021 2.4m, Q4 2021 2.3m, Q1 2022 1.4m, Q2 2022 1.2m -240.0k -240,000 -17.2%
11 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 312,000 $87.9m2.24% 2.24% AddedShares held: Q3 2021 636.0k, Q4 2021 488.0k, Q1 2022 236.0k, Q2 2022 312.0k +76.0k +76,000 32.2%
12 ALKERMES PLC SHS ALKS ALKS 2,924,000 $87.1m2.22% 2.22% AddedShares held: Q3 2021 2.4m, Q4 2021 3.2m, Q1 2022 1.8m, Q2 2022 2.9m +1.1m +1,100,000 60.3%
13 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 1,100,000 $78.7m2.01% 2.01% AddedShares held: Q3 2021 1.0m, Q4 2021 1.1m, Q1 2022 978.0k, Q2 2022 1.1m +122.0k +122,000 12.5%
14 DOLLAR GEN CORP NEW COM DG DG 308,143 $75.6m1.93% 1.93% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 308.1k
15 MEDTRONIC PLC SHS MDT MDT 800,000 $71.8m1.83% 1.83% AddedShares held: Q3 2021 450.0k, Q4 2021 712.0k, Q1 2022 468.0k, Q2 2022 800.0k +332.0k +332,000 70.9%
16 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 10,200,000 $71.5m1.82% 1.82% AddedShares held: Q3 2021 10.0m, Q4 2021 9.6m, Q1 2022 8.4m, Q2 2022 10.2m +1.8m +1,828,000 21.8%
17 ARGENX SE SPONSORED ADR ARGX ARGX 188,000 $71.2m1.82% 1.82% ReducedShares held: Q3 2021 208.0k, Q4 2021 188.0k, Q1 2022 200.0k, Q2 2022 188.0k -12.0k -12,000 -6.0%
18 DECIPHERA PHARMACEUTICALS IN COM DCPH DCPH 5,400,000 $71.0m1.81% 1.81% ReducedShares held: Q3 2021 678.0k, Q4 2021 3.4m, Q1 2022 5.8m, Q2 2022 5.4m -436.0k -436,000 -7.5%
19 CENTRAL GARDEN & PET CO CL A NON-VTG CENTA CENTA 1,624,000 $65.0m1.66% 1.66% AddedShares held: Q3 2021 956.0k, Q4 2021 1.1m, Q1 2022 1.5m, Q2 2022 1.6m +88.0k +88,000 5.7%
20 ILLUMINA INC COM ILMN ILMN 339,000 $62.5m1.59% 1.59% AddedShares held: Q3 2021 104.0k, Q4 2021 115.0k, Q1 2022 178.0k, Q2 2022 339.0k +161.0k +161,000 90.5%
21 LULULEMON ATHLETICA INC COM LULU LULU 228,573 $62.3m1.59% 1.59% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 228.6k
22 ANHEUSER BUSCH INBEV SA/NV SPONSORED ADR BUD BUD 1,136,000 $61.3m1.56% 1.56% AddedShares held: Q3 2021 936.0k, Q4 2021 536.0k, Q1 2022 978.0k, Q2 2022 1.1m +158.0k +158,000 16.2%
23 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 1,000,000 $60.8m1.55% 1.55% ReducedShares held: Q3 2021 380.0k, Q4 2021 892.0k, Q1 2022 1.0m, Q2 2022 1.0m -24.0k -24,000 -2.3%
24 KRAFT HEINZ CO COM KHC KHC 1,524,000 $58.1m1.48% 1.48% ReducedShares held: Q3 2021 572.0k, Q4 2021 1.4m, Q1 2022 1.6m, Q2 2022 1.5m -48.0k -48,000 -3.0%
25 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 836,000 $55.2m1.41% 1.41% AddedShares held: Q3 2021 0, Q4 2021 400.0k, Q1 2022 592.0k, Q2 2022 836.0k +244.0k +244,000 41.2%
26 TRACTOR SUPPLY CO COM TSCO TSCO 267,225 $51.8m1.32% 1.32% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 267.2k
27 BIOGEN INC COM BIIB BIIB 236,000 $48.1m1.23% 1.23% ReducedShares held: Q3 2021 372.0k, Q4 2021 460.0k, Q1 2022 572.0k, Q2 2022 236.0k -336.0k -336,000 -58.7%
28 MONDELEZ INTL INC CL A MDLZ MDLZ 756,000 $46.9m1.20% 1.20% AddedShares held: Q3 2021 428.0k, Q4 2021 345.0k, Q1 2022 400.0k, Q2 2022 756.0k +356.0k +356,000 89.0%
29 JOHNSON & JOHNSON COM JNJ JNJ 256,000 $45.4m1.16% 1.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 256.0k
30 POST HLDGS INC COM POST POST 536,000 $44.1m1.13% 1.13% ReducedShares held: Q3 2021 312.0k, Q4 2021 356.0k, Q1 2022 636.0k, Q2 2022 536.0k -100.0k -100,000 -15.7%
31 ADOBE INC COM ADBE ADBE 120,000 $43.9m1.12% 1.12% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 80.0k, Q2 2022 120.0k +40.0k +40,000 50.0%
32 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 278,000 $43.4m1.11% 1.11% ReducedShares held: Q3 2021 324.0k, Q4 2021 878.0k, Q1 2022 472.0k, Q2 2022 278.0k -194.0k -194,000 -41.1%
33 FIBROGEN INC COM COM 4,092,000 $43.2m1.10% 1.10% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 4.1m
34 WALMART INC COM WMT WMT 350,858 $42.7m1.09% 1.09% AddedShares held: Q3 2021 370.3k, Q4 2021 570.6k, Q1 2022 300.9k, Q2 2022 350.9k +50.0k +49,964 16.6%
35 FRESHPET INC COM FRPT FRPT 800,000 $41.5m1.06% 1.06% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 200.0k, Q2 2022 800.0k +600.0k +600,000 300.0%
36 UBER TECHNOLOGIES INC COM UBER UBER 2,000,000 $40.9m1.04% 1.04% AddedShares held: Q3 2021 972.0k, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 2.0m +764.0k +764,000 61.8%
37 BURLINGTON STORES INC COM BURL BURL 295,921 $40.3m1.03% 1.03% NewShares held: Q3 2021 213.0k, Q4 2021 0, Q1 2022 0, Q2 2022 295.9k
38 COLGATE PALMOLIVE CO COM CL CL 472,000 $37.8m0.97% 0.97% ReducedShares held: Q3 2021 272.0k, Q4 2021 268.0k, Q1 2022 636.0k, Q2 2022 472.0k -164.0k -164,000 -25.8%
39 I MAB SPONSORED ADS NBP NBP 3,324,000 $37.6m0.96% 0.96% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 3.3m
40 MICROSOFT CORP COM MSFT MSFT 136,000 $34.9m0.89% 0.89% AddedShares held: Q3 2021 92.0k, Q4 2021 98.0k, Q1 2022 120.0k, Q2 2022 136.0k +16.0k +16,000 13.3%
41 THERMO FISHER SCIENTIFIC INC COM TMO TMO 64,000 $34.8m0.89% 0.89% AddedShares held: Q3 2021 60.0k, Q4 2021 24.0k, Q1 2022 45.0k, Q2 2022 64.0k +19.0k +19,000 42.2%
42 PACIRA BIOSCIENCES INC COM PCRX PCRX 592,000 $34.5m0.88% 0.88% AddedShares held: Q3 2021 936.0k, Q4 2021 1.3m, Q1 2022 524.0k, Q2 2022 592.0k +68.0k +68,000 13.0%
43 FORMA THERAPEUTICS HLDGS INC SHS SHS 4,736,000 $32.6m0.83% 0.83% AddedShares held: Q3 2021 0, Q4 2021 1.9m, Q1 2022 3.2m, Q2 2022 4.7m +1.5m +1,536,000 48.0%
44 AVANTOR INC COM AVTR AVTR 1,000,000 $31.1m0.79% 0.79% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.0m
45 ZYMEWORKS INC COM ZYME ZYME 5,772,000 $30.6m0.78% 0.78% AddedShares held: Q3 2021 2.5m, Q4 2021 1.3m, Q1 2022 5.8m, Q2 2022 5.8m +12.0k +12,000 0.2%
46 M & T BK CORP COM MTB MTB 188,000 $30.0m0.76% 0.76% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 188.0k
47 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 148,000 $29.7m0.76% 0.76% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 148.0k +98.0k +98,000 196.0%
48 ALIBABA GROUP HLDG LTD SPONSORED ADS BABA BABA 250,000 $28.4m0.73% 0.73% AddedShares held: Q3 2021 100.0k, Q4 2021 0, Q1 2022 180.0k, Q2 2022 250.0k +70.0k +70,000 38.9%
49 UNITEDHEALTH GROUP INC COM UNH UNH 50,000 $25.7m0.66% 0.66% NewShares held: Q3 2021 100.0k, Q4 2021 0, Q1 2022 0, Q2 2022 50.0k
50 ULTA BEAUTY INC COM ULTA ULTA 66,431 $25.6m0.65% 0.65% NewShares held: Q3 2021 0, Q4 2021 150.6k, Q1 2022 0, Q2 2022 66.4k
51 LOWES COS INC COM LOW LOW 137,545 $24.0m0.61% 0.61% NewShares held: Q3 2021 196.4k, Q4 2021 68.9k, Q1 2022 0, Q2 2022 137.5k
52 PFIZER INC COM PFE PFE 456,000 $23.9m0.61% 0.61% NewShares held: Q3 2021 250.0k, Q4 2021 0, Q1 2022 0, Q2 2022 456.0k
53 NATERA INC COM NTRA NTRA 672,000 $23.8m0.61% 0.61% NewShares held: Q3 2021 216.0k, Q4 2021 316.0k, Q1 2022 0, Q2 2022 672.0k
54 AVALO THERAPEUTICS INC COM COM 47,576,000 $23.8m0.61% 0.61% UnchangedShares held: Q3 2021 45.0m, Q4 2021 45.0m, Q1 2022 47.6m, Q2 2022 47.6m
55 AEROJET ROCKETDYNE HLDGS INC COM AJRD AJRD 560,000 $22.7m0.58% 0.58% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 560.0k
56 AMAZON COM INC COM AMZN AMZN 208,098 $22.1m0.56% 0.56% NewShares held: Q3 2021 232.9k, Q4 2021 0, Q1 2022 0, Q2 2022 208.1k
57 ENERGIZER HLDGS INC NEW COM ENR ENR 764,000 $21.7m0.55% 0.55% ReducedShares held: Q3 2021 1.6m, Q4 2021 1.4m, Q1 2022 1.1m, Q2 2022 764.0k -384.0k -384,000 -33.5%
58 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 1,600,000 $21.1m0.54% 0.54% ReducedShares held: Q3 2021 0, Q4 2021 856.0k, Q1 2022 2.0m, Q2 2022 1.6m -400.0k -400,000 -20.0%
59 VIACOMCBS INC CL B CL B 836,000 $20.6m0.53% 0.53% NewShares held: Q3 2021 1.0m, Q4 2021 1.5m, Q1 2022 0, Q2 2022 836.0k
60 AEROCLEAN TECHNOLOGIES INC COM COM 1,500,000 $19.6m0.50% 0.50% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.5m
61 ALPHATEC HLDGS INC COM NEW ATEC ATEC 2,924,000 $19.1m0.49% 0.49% AddedShares held: Q3 2021 1.8m, Q4 2021 2.3m, Q1 2022 2.0m, Q2 2022 2.9m +888.0k +888,000 43.6%
62 TOAST INC CL A TOST TOST 1,472,000 $19.0m0.49% 0.49% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.3m, Q2 2022 1.5m +148.0k +148,000 11.2%
63 MACROGENICS INC COM MGNX MGNX 6,128,000 $18.1m0.46% 0.46% AddedShares held: Q3 2021 0, Q4 2021 2.7m, Q1 2022 5.0m, Q2 2022 6.1m +1.1m +1,128,000 22.6%
64 YUM BRANDS INC COM YUM YUM 151,713 $17.2m0.44% 0.44% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 151.7k
65 ALPHABET INC CAP STK CL A GOOGL GOOGL 7,000 $15.3m0.39% 0.39% ReducedShares held: Q3 2021 11.0k, Q4 2021 12.0k, Q1 2022 15.0k, Q2 2022 7.0k -8.0k -8,000 -53.3%
66 VOYAGER THERAPEUTICS INC COM VYGR VYGR 2,564,000 $15.2m0.39% 0.39% AddedShares held: Q3 2021 3.7m, Q4 2021 0, Q1 2022 2.0m, Q2 2022 2.6m +564.0k +564,000 28.2%
67 EVERBRIDGE INC COM EVBG EVBG 536,000 $14.9m0.38% 0.38% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 536.0k
68 BIONTECH SE SPONSORED ADS BNTX BNTX 100,000 $14.9m0.38% 0.38% AddedShares held: Q3 2021 52.0k, Q4 2021 68.0k, Q1 2022 75.0k, Q2 2022 100.0k +25.0k +25,000 33.3%
69 ROSS STORES INC COM ROST ROST 200,268 $14.1m0.36% 0.36% NewShares held: Q3 2021 389.0k, Q4 2021 0, Q1 2022 0, Q2 2022 200.3k
70 BLUCORA INC COM BCOR BCOR 736,000 $13.6m0.35% 0.35% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 736.0k
71 SPECTRUM PHARMACEUTICALS INC COM SPPI SPPI 17,100,000 $13.3m0.34% 0.34% UnchangedShares held: Q3 2021 16.4m, Q4 2021 9.7m, Q1 2022 17.1m, Q2 2022 17.1m
72 SCPHARMACEUTICALS INC COM SCPH SCPH 2,700,000 $13.0m0.33% 0.33% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.7m
73 SPDR S&P 500 ETF TR TR UNIT SPY SPY 33,500 $12.6m0.32% 0.32% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 33.5k
74 WHOLE EARTH BRANDS INC COM CL A COM CL A 1,956,000 $12.1m0.31% 0.31% AddedShares held: Q3 2021 1.5m, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 2.0m +156.0k +156,000 8.7%
75 META PLATFORMS INC CL A META META 75,000 $12.1m0.31% 0.31% ReducedShares held: Q3 2021 104.0k, Q4 2021 40.0k, Q1 2022 100.0k, Q2 2022 75.0k -25.0k -25,000 -25.0%
76 FOOT LOCKER INC COM FL FL 449,420 $11.3m0.29% 0.29% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 449.4k
77 CISCO SYS INC COM CSCO CSCO 256,000 $10.9m0.28% 0.28% NewShares held: Q3 2021 0, Q4 2021 261.0k, Q1 2022 0, Q2 2022 256.0k
78 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 268,000 $10.0m0.26% 0.26% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 180.0k, Q2 2022 268.0k +88.0k +88,000 48.9%
79 WYNN RESORTS LTD COM WYNN WYNN 172,000 $9.8m0.25% 0.25% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 236.0k, Q2 2022 172.0k -64.0k -64,000 -27.1%
80 BOSTON BEER INC CL A SAM SAM 32,000 $9.7m0.25% 0.25% AddedShares held: Q3 2021 0, Q4 2021 48.0k, Q1 2022 27.0k, Q2 2022 32.0k +5.0k +5,000 18.5%
81 ADVANTAGE SOLUTIONS INC COM CL A COM CL A 2,536,000 $9.6m0.25% 0.25% AddedShares held: Q3 2021 1.9m, Q4 2021 1.9m, Q1 2022 2.4m, Q2 2022 2.5m +136.0k +136,000 5.7%
82 XERIS BIOPHARMA HOLDINGS INC COM XERS XERS 5,824,000 $9.0m0.23% 0.23% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 7.5m, Q2 2022 5.8m -1.6m -1,640,993 -22.0%
83 NETFLIX INC COM NFLX NFLX 50,000 $8.7m0.22% 0.22% NewShares held: Q3 2021 56.0k, Q4 2021 0, Q1 2022 0, Q2 2022 50.0k
84 ADVANCED MICRO DEVICES INC COM AMD AMD 108,000 $8.3m0.21% 0.21% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 82.0k, Q2 2022 108.0k +26.0k +26,000 31.7%
85 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 1,178,000 $8.2m0.21% 0.21% AddedShares held: Q3 2021 624.0k, Q4 2021 800.0k, Q1 2022 1.0m, Q2 2022 1.2m +178.0k +178,000 17.8%
86 MONSTER BEVERAGE CORP NEW COM MNST MNST 84,000 $7.8m0.20% 0.20% NewShares held: Q3 2021 0, Q4 2021 60.0k, Q1 2022 0, Q2 2022 84.0k
87 SHOPIFY INC CL A SHOP SHOP 240,000 $7.5m0.19% 0.19% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 240.0k
88 CHIMERIX INC COM CMRX CMRX 3,524,000 $7.3m0.19% 0.19% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 3.5m
89 CROWDSTRIKE HLDGS INC CL A CRWD CRWD 42,000 $7.1m0.18% 0.18% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 42.0k
90 DATADOG INC CL A COM DDOG DDOG 70,000 $6.7m0.17% 0.17% AddedShares held: Q3 2021 0, Q4 2021 91.0k, Q1 2022 56.0k, Q2 2022 70.0k +14.0k +14,000 25.0%
91 EAGLE PHARMACEUTICALS INC COM EGRX EGRX 150,000 $6.7m0.17% 0.17% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 224.0k, Q2 2022 150.0k -74.0k -74,000 -33.0%
92 SKECHERS U S A INC CL A SKX SKX 186,386 $6.6m0.17% 0.17% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 186.4k
93 SERVICENOW INC COM NOW NOW 13,500 $6.4m0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 31.0k, Q1 2022 0, Q2 2022 13.5k
94 CELULARITY INC COM CL A COM CL A 1,868,128 $6.4m0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.9m
95 CARTERS INC COM CRI CRI 87,662 $6.2m0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 87.7k
96 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 164,000 $5.9m0.15% 0.15% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 164.0k
97 PALO ALTO NETWORKS INC COM PANW PANW 12,000 $5.9m0.15% 0.15% NewShares held: Q3 2021 0, Q4 2021 43.5k, Q1 2022 0, Q2 2022 12.0k
98 FIVE9 INC COM FIVN FIVN 65,000 $5.9m0.15% 0.15% NewShares held: Q3 2021 0, Q4 2021 75.0k, Q1 2022 0, Q2 2022 65.0k
99 ISHARES TR RUSSELL 2000 ETF IWM IWM 33,500 $5.7m0.14% 0.14% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 33.5k
100 PAYCOM SOFTWARE INC COM PAYC PAYC 20,000 $5.6m0.14% 0.14% NewShares held: Q3 2021 0, Q4 2021 21.0k, Q1 2022 0, Q2 2022 20.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
HOME DEPOT INC HD HD 349,897 $104.7m349.9k shares
TARGET CORP TGT TGT 321,698 $68.3m321.7k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 524,000 $62.1m524.0k shares
ORTHO CLINICAL DIAGNOSTICS H OCDX OCDX 3,324,000 $62.0m3.3m shares
FIVE BELOW INC FIVE FIVE 361,745 $57.3m361.7k shares
AUTOZONE INC AZO AZO 22,481 $46.0m22.5k shares
DECKERS OUTDOOR CORP DECK DECK 94,702 $25.9m94.7k shares
FRONTDOOR INC FTDR FTDR 692,000 $20.7m692.0k shares
JPMORGAN CHASE & CO JPM JPM 150,000 $20.4m150.0k shares
BEST BUY INC BBY BBY 200,000 $18.2m200.0k shares
RH RH RH 49,913 $16.3m49.9k shares
NRX PHARMACEUTICALS INC BRPA BRPA 6,259,781 $15.3m6.3m shares
ATERIAN INC ATER ATER 5,233,572 $12.7m5.2m shares
CHINOOK THERAPEUTICS INC ADRO ADRO 756,000 $12.4m756.0k shares
SPECTRUM BRANDS HLDGS INC NE SPB SPB 120,000 $10.6m120.0k shares
DYNATRACE INC DT DT 212,000 $10.0m212.0k shares
OLAPLEX HLDGS INC OLPX OLPX 636,000 $9.9m636.0k shares
ADAPTHEALTH CORP AHCO AHCO 500,000 $8.0m500.0k shares
PILGRIMS PRIDE CORP PPC PPC 300,000 $7.5m300.0k shares
SNOWFLAKE INC SNOW SNOW 32,000 $7.3m32.0k shares
ASSEMBLY BIOSCIENCES INC 2,000,000 $4.1m2.0m shares
ADIAL PHARMACEUTICALS INC 1,817,454 $3.7m1.8m shares
REMARK HLDGS INC MARK MARK 4,237,290 $3.5m4.2m shares
ERYTECH PHARMA 1,944,075 $3.4m1.9m shares
TAPESTRY INC TPR TPR 77,594 $2.9m77.6k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 90.

CompanyTickerStakeChange ScheduleLast filed
ARIDIS PHARMACEUTICALS INC ARDS · 13G · filed 2026-08-14 ARDS 11.4% no change 13G 2026-08-14
AVALON GLOBOCARE CORP 13G · filed 2026-08-14 10.0%≈ $465.2k no change 13G 2026-08-14
STRYVE FOODS INC SNAX · 13G · filed 2026-08-14 SNAX 10.0% no change 13G 2026-08-14
CALCIMEDICA INC 13G · filed 2026-08-14 10.0%≈ $3.5m new 13G 2026-08-14
ARCADIA BIOSCIENCES INC RKDA · 13G · filed 2026-08-14 RKDA 10.0%≈ $181.6k +2.2 pts 13G 2026-08-14
GLOBAL INTERACTIVE TECHNOLOG GITS · 13G · filed 2026-08-14 GITS 10.0% new 13G 2026-08-14
DOGWOOD THERAPEUTICS INC DWTX · 13G · filed 2026-08-14 DWTX 10.0%≈ $5.4m no change 13G 2026-08-14
GENERATION INCOME PPTYS INC COM NEW GIPR · 13G · filed 2026-08-14 GIPR 10.0% new 13G 2026-08-14
BIODEXA PHARMACEUTICALS PLC BDRX · 13G · filed 2026-08-14 BDRX 10.0% no change 13G 2026-08-14
TENON MEDICAL INC 13G · filed 2026-08-14 10.0%≈ $17.8k new 13G 2026-08-14
DECOY THERAPEUTICS INC DCOY · 13G · filed 2026-08-14 DCOY 10.0% new 13G 2026-08-14
ICECURE MED LTD ICCM · 13G · filed 2026-08-14 ICCM 10.0%≈ $1.5m new 13G 2026-08-14
ENVERIC BIOSCIENCES INC ENVB · 13G · filed 2026-08-14 ENVB 10.0%≈ $559.0k new 13G 2026-08-14
BLUEJAY DIAGNOSTICS INC BJDX · 13G · filed 2026-08-14 BJDX 10.0% +5.0 pts 13G 2026-08-14
INUVO INC INUV · 13G · filed 2026-08-14 INUV 10.0%≈ $2.1m new 13G 2026-08-14
IMUNON INC IMNN · 13G · filed 2026-08-14 IMNN 10.0%≈ $801.6k no change 13G 2026-08-14
FIBROBIOLOGICS INC FBLG · 13G · filed 2026-08-14 FBLG 10.0%≈ $693.5k new 13G 2026-08-14
CITIUS ONCOLOGY INC CTOR · 13G · filed 2026-08-14 CTOR 10.0%≈ $6.1m no change 13G 2026-08-14
CO-DIAGNOSTICS INC CODX · 13G · filed 2026-08-14 CODX 10.0%≈ $1.7m new 13G 2026-08-14
INSPIRA TECHNOLOGIES OXY BHN QTEX · 13G · filed 2026-05-15 QTEX 10.0%≈ $5.7m new 13G 2026-05-15
LM FDG AMER INC 13G · filed 2026-05-15 10.0%≈ $248.0k no change 13G 2026-05-15
CALIDI BIOTHERAPEUTICS INC 13G · filed 2026-05-15 10.0%≈ $189.0k +5.0 pts 13G 2026-05-15
BLUEJAY DIAGNOSTICS INC 13G · filed 2026-02-18 10.0% no change 13G 2026-02-18
ADIAL PHARMACEUTICALS INC ADIL · 13G · filed 2026-02-18 ADIL 10.0% new 13G 2026-02-18
DATA STORAGE CORP DTST · 13G · filed 2026-02-17 DTST 10.0%≈ $886.3k +2.7 pts 13G 2026-02-17